Fairview Capital Investment Management’s AB InBev BUD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.87M Sell
127,842
-13,085
-9% -$945K 0.48% 40
2025
Q4
$9.02M Sell
140,927
-43,235
-23% -$2.68M 0.46% 36
2025
Q3
$11M Sell
184,162
-2,295
-1% -$144K 0.56% 33
2025
Q2
$12.8M Buy
186,457
+11,643
+7% +$782K 0.66% 32
2025
Q1
$10.8M Buy
174,814
+8,985
+5% +$491K 0.57% 37
2024
Q4
$8.3M Sell
165,829
-40,235
-20% -$2.33M 0.43% 40
2024
Q3
$13.7M Buy
206,064
+4,129
+2% +$255K 0.74% 32
2024
Q2
$11.7M Buy
201,935
+7,225
+4% +$443K 0.66% 33
2024
Q1
$11.8M Buy
194,710
+15,857
+9% +$992K 0.67% 36
2023
Q4
$11.6M Sell
178,853
-3,809
-2% -$225K 0.69% 34
2023
Q3
$10.1M Buy
+182,662
New +$10.4M 0.65% 31

Other funds holding BUD

Fairview Capital Investment Management's BUD Position: Q1 2026 in Review

Fairview Capital Investment Management reduced its AB InBev (BUD) stake by 9.3% in Q1 2026, selling an estimated $945K and leaving 127,842 shares worth $8.87M. The position accounts for 0.48% of the portfolio, ranked #40.

Fairview Capital Investment Management first reported a position in BUD in Q3 2023 and has held it in 11 quarters since. The position peaked at $13.7M in Q3 2024. 545 funds tracked by Wall St. Rank hold BUD as of Q1 2026.

  • Fairview Capital Investment Management held 127,842 shares of AB InBev worth $8.87M as of Q1 2026.
  • Fairview Capital Investment Management sold 13,085 AB InBev shares in Q1 2026, an estimated $945K.
  • AB InBev made up 0.48% of Fairview Capital Investment Management's portfolio in Q1 2026, its #40 holding.
  • Fairview Capital Investment Management first reported a position in AB InBev in Q3 2023 and has held it in 11 quarters since.
  • Fairview Capital Investment Management's AB InBev position peaked at $13.7M in Q3 2024.
  • 545 funds tracked by Wall St. Rank held AB InBev as of Q1 2026.

Based on Fairview Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.